107 related articles for article (PubMed ID: 29107446)
1. Characterisation of the site-specific monoPEGylated rhG-CSF analogue pegteograstim.
Hong J; Lee B; Kang K; Lee SH; Ryu J; Jung G; Oh J; Jo EC; Kim CW
Biologicals; 2018 Jan; 51():54-61. PubMed ID: 29107446
[TBL] [Abstract][Full Text] [Related]
2. A new site-specific monoPEGylated filgrastim derivative prepared by enzymatic conjugation: Production and physicochemical characterization.
Scaramuzza S; Tonon G; Olianas A; Messana I; Schrepfer R; Orsini G; Caliceti P
J Control Release; 2012 Dec; 164(3):355-63. PubMed ID: 22735238
[TBL] [Abstract][Full Text] [Related]
3. Cysteine-specific PEGylation of rhG-CSF via selenylsulfide bond.
Kunstelj M; Fidler K; Skrajnar S; Kenig M; Smilović V; Kusterle M; Caserman S; Zore I; Porekar VG; Jevševar S
Bioconjug Chem; 2013 Jun; 24(6):889-96. PubMed ID: 23600957
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors.
Cho HW; Lee JW; Ju HY; Hyun JK; Yoo KH; Koo HH; Kim K; Sung KW
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e362-e367. PubMed ID: 34010932
[TBL] [Abstract][Full Text] [Related]
5. Optimization of PEGylation reaction time and molar ratio of rhG-CSF toward increasing bioactive potency of monoPEGylated protein.
Behi J; Hassiki R; Said NB; Bouhaouala-Zahar B; Benkhoud ML
Int J Biol Macromol; 2018 Apr; 109():888-895. PubMed ID: 29154875
[TBL] [Abstract][Full Text] [Related]
6. Modification of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and its derivative ND 28 with polyethylene glycol.
Yamasaki M; Asano M; Okabe M; Morimoto M; Yokoo Y
J Biochem; 1994 May; 115(5):814-9. PubMed ID: 7525544
[TBL] [Abstract][Full Text] [Related]
7. Effects of site-specific polyethylene glycol modification of recombinant human granulocyte colony-stimulating factor on its biologic activities.
Hao Y; Chen J; Wang X; Zhu H; Rong Z
BioDrugs; 2006; 20(6):357-62. PubMed ID: 17176123
[TBL] [Abstract][Full Text] [Related]
8. Site-specific PEGylation of engineered cysteine analogues of recombinant human granulocyte-macrophage colony-stimulating factor.
Doherty DH; Rosendahl MS; Smith DJ; Hughes JM; Chlipala EA; Cox GN
Bioconjug Chem; 2005; 16(5):1291-8. PubMed ID: 16173810
[TBL] [Abstract][Full Text] [Related]
9. [Study of target pegylated recombinant mutant human granulocyte colony stimulating factor].
Huang YS; Jin R; Liu XN; Wang CM; Rong YW; Chen Z
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):919-23. PubMed ID: 18051876
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conjugation with polyethylene glycol].
Puchkov IA; Kononova NV; Bobruskin AI; Bairamashvili DI; Mart'ianov VA; Shuster AM
Bioorg Khim; 2012; 38(5):545-54. PubMed ID: 23342488
[TBL] [Abstract][Full Text] [Related]
11. Structural identification and biological activity of positional isomers of long-acting and mono-PEGylated recombinant human granulocyte colony-stimulating factor with trimeric-structured methoxy polyethylene glycol N-hydroxysuccinimidyl functional group.
Son JP; Jun SW; Choi YK; Park HS; Son MK; Lee MY; Kang SH; Kang JS; Park YI
Anal Biochem; 2012 Apr; 423(2):286-93. PubMed ID: 22244804
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant granulocyte-colony stimulating factor (filgrastim): optimization of conditions of isolation and purification from inclusion body].
Kononova NV; Iakovlev AV; Zhuravko AM; Pankeev NN; Minaev SV; Bobruskin AI; Mart'ianov VA
Bioorg Khim; 2014; 40(5):550-9. PubMed ID: 25895350
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a Long-Acting Site-Specific PEGylated Murine GM-CSF Analog and Analysis of Its Hematopoietic Properties in Normal and Cyclophosphamide-Treated Neutropenic Rats.
Cox GN; Lee JI; Rosendahl MS; Chlipala EA; Doherty DH
Protein J; 2020 Apr; 39(2):160-173. PubMed ID: 32172395
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
15. Tailored PEG for rh-G-CSF analogue site-specific conjugation.
Salmaso S; Bersani S; Scomparin A; Mastrotto F; Scherpfer R; Tonon G; Caliceti P
Bioconjug Chem; 2009 Jun; 20(6):1179-85. PubMed ID: 19469471
[TBL] [Abstract][Full Text] [Related]
16. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-stimulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography.
Yun Q; Yang RE; Chen T; Bi J; Ma G; Su Z
J Biotechnol; 2005 Jul; 118(1):67-74. PubMed ID: 15904987
[TBL] [Abstract][Full Text] [Related]
17. Doping control analysis of filgrastim in equine plasma and its application to a co-administration study of filgrastim and recombinant human erythropoietin in the horse.
Ho EN; Kwok WH; Lau MY; Wong AS; Lam KK; Stewart BD; Wan TS
J Chromatogr A; 2014 Apr; 1338():92-101. PubMed ID: 24636755
[TBL] [Abstract][Full Text] [Related]
18. Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities.
Tiwari D; Haque S; Jawed A; Mishra MK; Govender T; Kruger HG
Protein Pept Lett; 2015; 22(10):877-84. PubMed ID: 26216266
[TBL] [Abstract][Full Text] [Related]
19. Process Development for the Production and Purification of PEGylated RhG-CSF Expressed in Escherichia coli.
Mohammadi Z; Alijanianzadeh M; Khalilzadeh R; Khodadadi S
Protein Pept Lett; 2022; 29(4):293-305. PubMed ID: 35081882
[TBL] [Abstract][Full Text] [Related]
20. [Study on rhG-CSF modified with polyethylene glycol].
Zhang LL; Zheng CY; Lei JD; Ma GH; Su ZG; Wang L
Sheng Wu Gong Cheng Xue Bao; 2005 Nov; 21(6):965-9. PubMed ID: 16468354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
